secwatch.observer — SEC 8-K summary
======================================

Issuer:     HARROW, INC. (HROW)
CIK:        0001360214
Form:       8-K
Filed at:   2022-12-16T23:59:59+00:00
Accession:  0001493152-22-035767
Event type: debt
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Harrow Health secures $125M financing package (notes, equity, loan) to fund acquisition
--------------------------------------------------------------------------------

- Common stock offering: 2,376,426 shares at $10.52 for gross proceeds of $25M, closed Dec 16.
- Senior notes offering: $35M principal of 11.875% notes due 2027, priced Dec 16, closing expected Dec 20.
- B. Riley affiliate committed $65M secured loan at 10.875% fixed interest rate.
- Management and directors purchased $950,000 of the senior notes.
- Proceeds, along with sale of non-ophthalmology assets, to fund recently announced acquisition and general purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1360214/000149315222035767/0001493152-22-035767-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1360214/000149315222035767/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-035767

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer